The Benefits of the Use of the Feuerstein Cognitive Training Method on Cognitive Function in Community-dwelling Older Patients With Mild Cognitive Impairment: a Pilot Study

NCT02388451 | Completed DMC

• 1 other identifier: 001
• Study Type: interventional
• Target: 11
• Locations: 1 country
• Sites: 1

Brief Summary

15 subjects conforming to inclusion and exclusion criteria with a known clinical diagnosis of MCI and who provide informed consent will undergo cognitive and functional assessment to confirm the diagnosis of MCI. Baseline assessment using the Mindstreams Mild Cognitive Impairment Computerized Assessment Battery will be performed. Subjects will then participate 30 twice weekly meetings of 90 minutes duration each (for a total of 15 weeks). Mindstreams testing will be repeated after 15 sessions and at completion of the study.

Conditions

Mild Cognitive Impairment

Keywords

Mild Cognitive Impairment

Outcome Measures

Primary Outcomes (1)

• Mindstreams Mild Cognitive Impairment Computerized Assessment Battery

  The Mindstreams Mild Cognitive Impairment Computerized Assessment Battery developed by Neurotrax Corp. provides index scores in multiple cognitive domains, as well as a Global cognitive score

  Change from Baseline Cognitive Function at 15 weeks

Study Arms (1)

Feuerstein Program

EXPERIMENTAL

15 subjects conforming to inclusion and exclusion criteria with a known clinical diagnosis of MCI and who provide informed consent will undergo cognitive and functional assessment to confirm the diagnosis of MCI. Baseline assessment using the Mindstreams Mild Cognitive Impairment Computerized Assessment Battery will be performed. Subjects will then participate 30 twice weekly meetings of 90 minutes duration each (for a total of 15 weeks). Mindstreams testing will be repeated after 15 sessions and at completion of the study.

Device: Feuerstein Program

Interventions

Feuerstein Program DEVICE

The IE activity is administered by instructors in groups of 10 to 15 participants. The intervention comprises 30 twice weekly meetings of 90 minutes duration per group.

Feuerstein Program

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Age 65 years and older
• Able to read and speak Hebrew
• Provide informed consent for participation in the study
• Clinical diagnosis of MCI based on Consensus Criteria
• A score of lower than 95 on the Memory Index of the Mindstreams Mild Cognitive Impairment Computerized Assessment Battery

You may not qualify if:

• A medical condition (such as advanced heart failure, unstable ischemic heart disease, a lung condition with dyspnea on mild effort, intractable pain) or functional impairment (especially limiting mobility without the home) that does not allow the subject to participate in the training activities for the full duration of the study
• A diagnosis of depression, bipolar disorder or schizophrenia
• A cognitive diagnosis other than MCI, such as delirium, dementia or mental retardation
• Visual impairment not corrected by the use of spectacles
• Hearing impairment not corrected by hearing aids

Sponsors & Collaborators

• Meir Medical Center: lead

Study Sites (1)

Yan Press

Beersheba, Israel

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 26, 2015
• First Posted: March 17, 2015
• Study Start: December 1, 2015
• Primary Completion: July 1, 2017
• Study Completion: August 1, 2018
• Last Updated: January 23, 2019

Record last verified: 2019-01

Locations

IL (1)